These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25708417)

  • 1. Biphalin analogs containing β(3)-homo-amino acids at the 4,4' positions: Synthesis and opioid activity profiles.
    Frączak O; Lasota A; Kosson P; Leśniak A; Muchowska A; Lipkowski AW; Olma A
    Peptides; 2015 Apr; 66():13-8. PubMed ID: 25708417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent biphalin analogs with µ/δ mixed opioid activity: in vivo and in vitro biological evaluation.
    Costante R; Pinnen F; Stefanucci A; Mollica A
    Arch Pharm (Weinheim); 2014 May; 347(5):305-12. PubMed ID: 24798820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological consequences of replacing D-Ala in biphalin with amphiphilic α-alkylserines.
    Frączak O; Lasota A; Leśniak A; Lipkowski AW; Olma A
    Chem Biol Drug Des; 2014 Aug; 84(2):199-205. PubMed ID: 24674466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive profile of potent opioid peptide AM94, a fluorinated analogue of biphalin with non-hydrazine linker.
    Mollica A; Costante R; Stefanucci A; Pinnen F; Lucente G; Fidanza S; Pieretti S
    J Pept Sci; 2013 Apr; 19(4):233-9. PubMed ID: 23136069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological properties of a new fluorescent opioid peptide analog.
    Lukowiak M; Kosson P; Hennink WE; Lipkowski AW
    Pharmacol Rep; 2009; 61(4):727-31. PubMed ID: 19815956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
    Misicka A; Lipkowski AW; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
    Life Sci; 1997; 60(15):1263-9. PubMed ID: 9096243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
    Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues.
    Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A
    J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, binding affinities and metabolic stability of dimeric dermorphin analogs modified with β3-homo-amino acids.
    Frączak O; Lasota A; Tymecka D; Kosson P; Muchowska A; Misicka A; Olma A
    J Pept Sci; 2016 Apr; 22(4):222-7. PubMed ID: 27028206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of biphalin analogs and their biological evaluation on opioid receptors.
    Feliciani F; Pinnen F; Stefanucci A; Costante R; Cacciatore I; Lucente G; Mollica A
    Mini Rev Med Chem; 2013 Jan; 13(1):11-33. PubMed ID: 22512573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain and spinal cord distribution of biphalin: correlation with opioid receptor density and mechanism of CNS entry.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Neurochem; 1997 Sep; 69(3):1236-45. PubMed ID: 9282948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic biphalin analogues with a novel linker lead to potent agonist activities at mu, delta, and kappa opioid receptors.
    Remesic M; Macedonio G; Mollica A; Porreca F; Hruby V; Lee YS
    Bioorg Med Chem; 2018 Jul; 26(12):3664-3667. PubMed ID: 29858157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of the first cyclic biphalin analogues.
    Mollica A; Davis P; Ma SW; Porreca F; Lai J; Hruby VJ
    Bioorg Med Chem Lett; 2006 Jan; 16(2):367-72. PubMed ID: 16275086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological active analogues of the opioid peptide biphalin: mixed α/β(3)-peptides.
    Mollica A; Pinnen F; Costante R; Locatelli M; Stefanucci A; Pieretti S; Davis P; Lai J; Rankin D; Porreca F; Hruby VJ
    J Med Chem; 2013 Apr; 56(8):3419-23. PubMed ID: 23547584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAPP analogs containing β3 -homo-amino acids: synthesis and receptor binding.
    Podwysocka D; Kosson P; Lipkowski AW; Olma A
    J Pept Sci; 2012 Sep; 18(9):556-9. PubMed ID: 22786725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular dynamics study on opioid activities of biphalin molecule.
    Hsieh JY; Chiang TY; Chen JL; Chen YW; Lin HC; Hwang CC
    J Mol Model; 2011 Oct; 17(10):2455-64. PubMed ID: 21181216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analgesic activity of biphalin and its analog AM 94 in rats.
    Leone S; Chiavaroli A; Orlando G; Mollica A; Di Nisio C; Brunetti L; Vacca M
    Eur J Pharmacol; 2012 Jun; 685(1-3):70-3. PubMed ID: 22546229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.